Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Harrison

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Cancer Chemotherapy and Pharmacology|January 11, 1992
Antitumor drug cross-resistance in vivo in a murine P388 leukemia resistant to ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7 - ylcarbamate 2-hydroxyethanesulfonate hydrate (NSC 370,147) 370147W R Waud, S D Harrison, C G Temple, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 1996
Loss of tramtrack gene activity results in ectopic R7 cell formation, even in a sina mutant backgroundZ C Lai, S D Harrison, F Karim, et al.
Leukemia Research|January 1, 1991
Modulation of cytosine arabinoside toxicity by 3-deazauridine in a murine leukemia modelJ L Grem, J Plowman, L Rubinstein, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivoS D Harrison, J Plowman, D J Dykes, et al.
Journal of Psychosomatic Research|January 1, 1984
Life change and onset of cancer in identical twinsC K Smith, S D Harrison, C Ashworth, et al.
Oncology Reports|July 31, 1998
Binding of the epoxide cryptophycin analog, LY355703 to albumin and its effect on in vitro antiproliferative activityR M Schultz, C Shih, P G Wood, et al.
Cancer Research|April 15, 1991
Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brainS D Harrison, J Plowman, D J Dykes, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II)L J Wilkoff, E A Dulmadge, M W Trader, et al.
Cancer Research|August 1, 1978
Hematology and clinical chemistry reference values for C57BL/6 X DBA/2 F1 miceS D Harrison, J A Burdeshaw, R G Crosby, et al.
Cancer Chemotherapy and Pharmacology|January 11, 1991
Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemiaW R Waud, S D Harrison, K S Gilbert, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|January 11, 1992
Antitumor drug cross-resistance in vivo in a murine P388 leukemia resistant to ethyl 5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7 - ylcarbamate 2-hydroxyethanesulfonate hydrate (NSC 370,147) 370147W R Waud, S D Harrison, C G Temple, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 1996
Loss of tramtrack gene activity results in ectopic R7 cell formation, even in a sina mutant backgroundZ C Lai, S D Harrison, F Karim, et al.
Leukemia Research|January 1, 1991
Modulation of cytosine arabinoside toxicity by 3-deazauridine in a murine leukemia modelJ L Grem, J Plowman, L Rubinstein, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivoS D Harrison, J Plowman, D J Dykes, et al.
Journal of Psychosomatic Research|January 1, 1984
Life change and onset of cancer in identical twinsC K Smith, S D Harrison, C Ashworth, et al.
Oncology Reports|July 31, 1998
Binding of the epoxide cryptophycin analog, LY355703 to albumin and its effect on in vitro antiproliferative activityR M Schultz, C Shih, P G Wood, et al.
Cancer Research|April 15, 1991
Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brainS D Harrison, J Plowman, D J Dykes, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II)L J Wilkoff, E A Dulmadge, M W Trader, et al.
Cancer Research|August 1, 1978
Hematology and clinical chemistry reference values for C57BL/6 X DBA/2 F1 miceS D Harrison, J A Burdeshaw, R G Crosby, et al.
Cancer Chemotherapy and Pharmacology|January 11, 1991
Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemiaW R Waud, S D Harrison, K S Gilbert, et al.
Pageof 9